Matrix Metalloproteinase-9 Degrades Amyloid-β Fibrils in Vitro and Compact Plaques in Situ
Open Access
- 1 August 2006
- journal article
- Published by Elsevier BV in Journal of Biological Chemistry
- Vol. 281 (34), 24566-24574
- https://doi.org/10.1074/jbc.m602440200
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Curcumin Inhibits Formation of Amyloid β Oligomers and Fibrils, Binds Plaques, and Reduces Amyloid in VivoPublished by Elsevier BV ,2005
- Contribution of glial cells to the development of amyloid plaques in Alzheimer’s diseaseNeurobiology of Aging, 2004
- Residues 17–20 and 30–35 of beta‐amyloid play critical roles in aggregationJournal of Neuroscience Research, 2003
- Differential Degradation of Amyloid β Genetic Variants Associated with Hereditary Dementia or Stroke by Insulin-degrading EnzymePublished by Elsevier BV ,2003
- Alzheimer's Disease β-Amyloid Peptide Is Increased in Mice Deficient in Endothelin-converting EnzymePublished by Elsevier BV ,2003
- Gelatinase B Is Required for Alveolar Bronchiolization after Intratracheal BleomycinThe American Journal of Pathology, 2000
- Common core structure of amyloid fibrils by synchrotron X-ray diffraction 1 1Edited by F. E. CohenJournal of Molecular Biology, 1997
- Differential matrix metalloproteinase expression in cases of multiple sclerosis and strokeNeuropathology and Applied Neurobiology, 1997
- Alzheimer's β‐amyloid peptide specifically interacts with and is degraded by insulin degrading enzymeFEBS Letters, 1994
- Substitutions of hydrophobic amino acids reduce the amyloidogenicity of Alzheimer's disease βA4 peptidesJournal of Molecular Biology, 1992